DEF6 and autoimmune disease: Along with DEF6, phosphorylation of several proteins that we have identified upon TCR stimulation and/or Treg-mediated suppression of Tcons open interesting avenues for revisiting the role of CD4+ T cells as targets for therapeutic intervention particularly in autoimmune diseases, and possibly in immunological and other malignancies as well.